Measure Quality Attributes Faster mRNA And LNP Analytical Services

Efficiently and confidently assess critical quality attributes (CQAs) throughout every phase of drug development—from discovery to clinical trials—with our mRNA and LNP Analytical Services.

To address the specific requirements of mRNA drug discovery and development, Vernal offers both standardized and customized analytical methods. Whether you're progressing with vaccines, gene therapies, or innovative formulations, we deliver the insights necessary for deeper understanding and informed decision-making, thereby enhancing risk management and minimizing costly delays in your development timeline.

Ultimately, we enable you to translate your results more quickly into safer, more effective mRNA medicines, significantly improving the lives of patients in need. Learn more by downloading the brochure below.